Andrew MacKinnon examines a Danish drug that fights obesity by suppressing appetite. With demand growing, the drug’s developer Novo Nordisk is now worth over $500bn. But is it the answer for obesity? Show more
Discover 11,128,835 listings and 279,834 playable programmes from the BBC
Andrew MacKinnon examines a Danish drug that fights obesity by suppressing appetite. With demand growing, the drug’s developer Novo Nordisk is now worth over $500bn. But is it the answer for obesity? Show more
BBC ALBA
